Patents by Inventor Walter Kraus

Walter Kraus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11919951
    Abstract: The invention relates to antibodies directed against an epitope located within the C-terminal portion of CLDN6 which are useful, for example, in diagnosing cancer and/or in determining whether cancer cells express CLDN6.
    Type: Grant
    Filed: February 7, 2022
    Date of Patent: March 5, 2024
    Assignees: Astellas Pharma Inc., TRON-Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz
    Inventors: Rita Mitnacht-Kraus, Stefan Wöll, Korden Walter, Özlem Türeci, Ugur Sahin
  • Patent number: 4500451
    Abstract: Protein PP.sub.13 is isolated from human placental tissues using a variety of methods, e.g., immunoadsorption. The protein has utility in production of an antiserum which has diagnostic applications. The placental specific proteins (e.g., PP.sub.13) are frequently detected in increasing amounts in women as pregnancy advances, and in patients with tumors especially of the tryphoblastic and embryonal types.
    Type: Grant
    Filed: August 18, 1983
    Date of Patent: February 19, 1985
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Hans Bohn, Walter Kraus
  • Patent number: 4302385
    Abstract: A new placenta-specific protein (PP.sub.10) and a process for isolating it are described.
    Type: Grant
    Filed: December 17, 1979
    Date of Patent: November 24, 1981
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Hans Bohn, Walter Kraus